Australia markets open in 4 hours 51 minutes

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.9150-0.3850 (-8.95%)
As of 03:09PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18181815
Avg. Estimate-0.49-0.49-1.96-1.81
Low estimate-0.67-0.65-2.62-2.12
High estimate-0.43-0.38-1.67-1.43
Year ago EPS-0.19-0.54-1.64-1.96
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14141613
Avg. Estimate1.11M1.13M4.2M2.91M
Low estimateN/AN/AN/AN/A
High estimate5M5M20M20M
Year ago sales58.98M5.53M65.53M4.2M
Sales growth (year/est)-98.10%-79.60%-93.60%-30.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.62-0.59-0.57-0.52
Actual EPS-0.19-0.54-0.46-0.45
Difference0.430.050.110.07
Surprise %69.40%8.50%19.30%13.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.49-0.49-1.96-1.81
7 days ago-0.49-0.49-1.96-1.81
30 days ago-0.49-0.49-1.93-1.76
60 days ago-0.52-0.51-2.03-1.67
90 days ago-0.52-0.51-2.03-1.66
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesFATEIndustrySector(s)S&P 500
Current qtr.-157.90%N/AN/AN/A
Next qtr.9.30%N/AN/AN/A
Current year-19.50%N/AN/AN/A
Next year7.70%N/AN/AN/A
Next 5 years (per annum)-37.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A